Eupraxia Pharmaceuticals (EPRX) Current Leases (2022 - 2026)
Eupraxia Pharmaceuticals' (EPRX) quarterly Current Leases came in at $203510.0 in Q1 2026, up 285.63% year-on-year from $52774.0 in Q1 2025, and up 159.41% on a QoQ basis from $78452.0 in Q4 2025.
Eupraxia Pharmaceuticals (EPRX) Current Leases (2022 - 2026) Analysis & Trends
Eupraxia Pharmaceuticals (EPRX) has 5 years of Current Leases data on file, last reported at $203510.0 in Q1 2026.
- On a quarterly basis, Current Leases rose 285.63% year-over-year to $203510.0 in Q1 2026; TTM through Mar 2026 was $203510.0, a 285.63% increase from a year earlier, with the FY2025 full-year figure at $78452.0, up 9.17% from the prior year.
- Current Leases for Q1 2026 stood at $203510.0, up from $78452.0 in the prior quarter.
- Over the last five years, Current Leases for EPRX reached as high as $203510.0 in Q1 2026 and fell as low as $35065.0 in Q2 2025.
- Historically, Current Leases has averaged $77689.4 across 5 years, with a median of $62587.5 in 2023.
- Across the five-year window, Current Leases climbed 5.78% in 2023 and soared 285.63% in 2026, its largest moves.
- Year by year, Current Leases stood at $50403.0 in 2022, then advanced by 5.78% to $53316.0 in 2023, then surged by 34.78% to $71859.0 in 2024, then gained by 9.17% to $78452.0 in 2025, then soared by 159.41% to $203510.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $203510.0 in Q1 2026, $78452.0 in Q4 2025, and $76136.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Eupraxia Pharmaceuticals | 357.29 Mn | 355.69 Mn | - | 203,510.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 203,510.00 |
| Dec 31, 2025 | 78,452.00 |
| Sep 30, 2025 | 76,136.00 |
| Jun 30, 2025 | 35,065.00 |
| Mar 31, 2025 | 52,774.00 |
| Dec 31, 2024 | 71,859.00 |
| Dec 31, 2023 | 53,316.00 |
| Dec 31, 2022 | 50,403.00 |